Lung Cancer Human Lung-P2 Total RNA, Donor 360 (CAT#: DBFF-0624-HY5121)

Datasheet

Overview

Lung cancer is a malignant tumor that originates in the cells of the lungs. It usually forms on the bronchial mucosa of the lungs, and over time these cancer cells can spread to other sites. Lung Cancer Human Lung-P2 Total RNA, Donor 360 is extracted from lung tissue of a single lung cancer human donor using a classical guanidine isothiocyanate-phenol: chloroform extraction method. RNA goes through rigorous quality control procedures to ensure the highest quality possible.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Male

Age At Sampling

72 yrs

Medical Diagnosis

Carcinoma of lung, large cell

Product Description

Species

Human

Tissue Name

Lung

Sample Diagnosis Category

Lung Cancer

28S/18S Ratio

1.40

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Northern blotting, ribonuclease protection assay, polymerase chain reaction analysis, rapid amplification of cDNA end analysis, cDNA synthesis, RNA differential display, microRNA studies, and RNA library construction.

Product Properties

Normal Ratio

Lesional Ratio

Tumor Ratio

90%

Hypocellular/Acellular Tumor Stroma Ratio

10%

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

Tumor Stage

IIB

Primary Tumor (T)

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use